Evaluate Pharma offers clients forecasts of the pharmaceutical industry in its annual World Preview.
The top R&D focus areas and forecasted dollar amount:
1. Oncology ($91.1 billion)
2. Central nervous system ($31 billion)
3. Musculoskeletal ($19.9 billion)
4. Cardiovascular ($19.7 billion)
5. Immunomodulators ($15 billion)
6. Respiratory ($9.2 billion)
7. Gastro-Intestinal ($8.4 billion)
8. Systemic Anti-infectives ($8.2 billion)
9. Blood ($6.4 billion)
10. Sensory organs ( $4.9 billion)
11. Dermatology ($3.9 billion)
12. Endocrine ($3.9 billion)
13. Genito-Urinary ($2 billion)
14. Other ($4.1 billion)
More articles on pharmacy:
Lupin recalls 18,408 bottles of antibiotic in US
Bluebird Bio prices gene therapy at $1.8M
10 hospitals seeking pharmacy leaders
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
